NZD/USD shows signs of potential exhaustion


  NZD/USD Analysis. Monetary policy conundrum adds uncertainty ahead of September RBNZ meeting. NZD/USD Rejected at the key weekly level around 0.6785. Signs of NZDUSD weakness. macd, RSI and bearish engulfment. IG client sentiment :Recent dovishness has invalidated the typical opposing sentiment view. NZD/USD faces resistance as RBNZ considers usingRead More →

AstraZeneca approached Gilead about potential merger


2/2 © Reuters. FILE PHOTO: Gilead Sciences Inc pharmaceutical company is seen during the outbreak of the coronavirus disease (COVID-19), in California 2/2 By Paul Sandle and Pamela Barbaglia LONDON (Reuters) – Britain’s AstraZeneca Plc (L:) has approached U.S. rival Gilead Sciences Inc (O:) about a possible merger that wouldRead More →